9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Estimated reading time: < 1 min

Condition: Mesothelioma

Estimated Enrollment: 240

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Recruiting

Study Results: No Results Available

Outcome Measures: Pre-treatment Prognostic Algorithm Validation,  Evaluation of Molecular Tests Base on RNA Expression,  ,

Interventions: MPT Test, CLDN15/VIM Test

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Diagnostic,

Primary Completion Date: January 1, 2022

Completion Date: October 1, 2023

Last  Posted Date: February 12, 2019

Location: Brigham and Women’s Hospital, Boston, Massachusetts, United States

Website Link: https://ClinicalTrials.gov/show/NCT03683680

Was this article helpful?
Dislike 0